Comments on: Gilead to buy 49.9% stake in Pionyr Immunotherapeutics for $275m /news/gilead-pionyr-immunotherapeutics/ The leading site for news and procurement in the pharmaceutical industry Wed, 24 Jun 2020 07:32:30 +0000 hourly 1 https://wordpress.org/?v=6.6.2